Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find Radio Compass News for Nebivolol

    Client Email Product

    Nebivolol

    APIs // Active Pharmaceutical Ingredients

    PRICE INFORMATION

    INTERMEDIATES

    DOSSIERs // Finished Dosage Formulations

    DRUG PRODUCT COMPOSITION

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    ANALYTICAL SOLUTION(s)

    DIGITAL CONTENT

    PharmaCompass
    Related ProductsRelated Products
    API SUPPLIERS
    API Suppliers

    API Suppliers

    40
    US DMFs Filed

    US DMFs Filed

    14
    CEP/COS Certifications

    CEP/COS Certifications

    4
    JDMFs Filed

    JDMFs Filed

    0

    Other Certificates

    Other Certificates

    7
    Other Suppliers

    Other Suppliers

    30
    API REF. PRICE (USD / KG)
    2,409

    API Market Place

    24
    INTERMEDIATES
    21
    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    72
    Europe

    Europe

    77
    Canada

    Canada

    4
    Australia

    Australia

    30
    South Africa

    South Africa

    2
    Uploaded Dossiers

    Uploaded Dossiers

    44
    GLOBAL SALES (USD Million)

    U.S. Medicaid

    2,660.00

    Annual Reports

    586.00

    FDF Market Place

    5
    EXCIPIENTS
    184
    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    2

    USFDA Exclusivities

    0

    DIGITAL CONTENT

    Blog #PharmaFlow

    2

    News

    23
    REF STANDARD

    EDQM

    0

    USP

    6

    JP

    0

    Other Listed Suppliers

    6
    SERVICES
    1
    left grey arrow
    right gray arrow
    • TABLET;ORAL - EQ 5MG BASE;80MG
    • TABLET;ORAL - EQ 10MG BASE
    • TABLET;ORAL - EQ 2.5MG BASE
    • TABLET;ORAL - EQ 20MG BASE
    • TABLET;ORAL - EQ 5MG BASE
    Full View ScreenFull Screen View
    Mankind's Generic Nebivolol Hydrochloride Receives Approval in the U.S.
    Mankind's Generic Nebivolol Hydrochloride Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216172

    FDA
    14 Nov 2022
    Share Share
    Prinston's Generic Nebivolol HCL, Valsartan Receives Approval in the U.S.
    Prinston's Generic Nebivolol HCL, Valsartan Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210596

    FDA
    19 Sep 2022
    Share Share
    ANI Pharmaceuticals Reports Second Quarter 2022 Financial Results
    ANI Pharmaceuticals Reports Second Quarter 2022 Financial Results

    https://www.businesswire.com/news/home/20220808005200/en

    BUSINESS WIRE
    08 Aug 2022
    Share Share
    PRINSTON 's Generic Nebivolol Hydrochloride Receives Approval in US
    PRINSTON 's Generic Nebivolol Hydrochloride Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212682

    FDA
    07 Apr 2022
    Share Share
    Unichem's Generic Nebivolol Hydrochloride Receives Approval in the U.S.
    Unichem's Generic Nebivolol Hydrochloride Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213830

    FDA
    15 Mar 2022
    Share Share
    AbbVie escapes antitrust claims over blood pressure med Bystolic
    AbbVie escapes antitrust claims over blood pressure med Bystolic

    https://www.fiercepharma.com/pharma/abbvie-notches-reprieve-bystolic-antitrust-case

    F. Kansteiner FIERCEPHARMA
    27 Jan 2022
    Share Share
    Cadila Pharms' Generic Nebivolol Hydrochloride Receives Approval in the U.S.
    Cadila Pharms' Generic Nebivolol Hydrochloride Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208717

    FDA
    17 Dec 2021
    Share Share
    Aurobindo Pharma's Generic Nebivolol Hydrochloride Receives Approval in the U.S.
    Aurobindo Pharma's Generic Nebivolol Hydrochloride Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211053

    FDA
    17 Dec 2021
    Share Share
    Reyoung's Generic Nebivolol Hydrochloride Receives Approval in the U.S.
    Reyoung's Generic Nebivolol Hydrochloride Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212917

    FDA
    17 Dec 2021
    Share Share
    ANI Pharmaceuticals Announces Launch of Nebivolol Tablets
    ANI Pharmaceuticals Announces Launch of Nebivolol Tablets

    https://www.businesswire.com/news/home/20210917005104/en

    BUSINESSWIRE
    17 Sep 2021
    Share Share
    Hetero Labs Unit`s Generic nebivolol hydrochloride Approval In US
    Hetero Labs Unit`s Generic nebivolol hydrochloride Approval In US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203825

    FDA
    06 Nov 2020
    Share Share
    Valsartan products not currently recalled - Updated November 27, 2018
    Valsartan products not currently recalled - Updated November 27, 2018

    https://www.fda.gov/downloads/Drugs/DrugSafety/UCM615704.pdf

    FDA
    28 Nov 2018
    Share Share
    Torrent Pharma's Generic Olmesartan Medoxomil Receives Approval In US
    Torrent Pharma's Generic Olmesartan Medoxomil Receives Approval In US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203966

    FDA
    08 Mar 2018
    Share Share
    Bystolic® (Nebivolol Hydrochloride): Allergan Sales V. Aurobindo Pharma Usa
    Bystolic® (Nebivolol Hydrochloride): Allergan Sales V. Aurobindo Pharma Usa

    https://insight.rpxcorp.com/litigation_documents/12775634

    PATENT LITIGATION
    19 Jan 2018
    Share Share
    FDA Confirms Paragraph IV Patent Challenge of Byvalson (Nebivolol Hydrochloride and Valsartan)Tablets
    FDA Confirms Paragraph IV Patent Challenge of Byvalson (Nebivolol Hydrochloride and Valsartan)Tablets

    https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-byvalson-nebivolol-hydrochloride-and-valsartantablets-1503543885.pdf

    FDA
    23 Aug 2017
    Share Share
    US says Allergan's Units to Pay $38 Million to Settle Kickback Allegations
    US says Allergan's Units to Pay $38 Million to Settle Kickback Allegations

    http://www.reuters.com/article/us-allergan-usa-forestlabs-idUSKBN1442BK

    Susan Heavey REUTERS
    16 Dec 2016
    Share Share
    Forest's Byvalson (Nebivolol; Valsartan) approved in US for Hypertension
    Forest's Byvalson (Nebivolol; Valsartan) approved in US for Hypertension

    https://www.pharmacompass.com/pdf/news/forests-byvalson-nebivolol-valsartan-approved-in-us-for-hypertension-1465303026.pdf

    FDA
    03 Jun 2016
    Share Share
    Watson's Generic Nebivolol Hydrochloride approved in US for Hypertension
    Watson's Generic Nebivolol Hydrochloride approved in US for Hypertension

    https://www.pharmacompass.com/pdf/news/watsons-generic-nebivolol-hydrochloride-approved-in-us-for-hypertension-1449058849.pdf

    FDA
    01 Dec 2015
    Share Share
    Alkem's Generic Nebivolol Hcl Approved in US For Hypertension
    Alkem's Generic Nebivolol Hcl Approved in US For Hypertension

    http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/203741Orig1s000ltr.pdf

    Press Release FDA
    27 Jun 2015
    Share Share
    Actavis wins more hearts on Wall Street as 'top 4' Morgan Stanley pick
    Actavis wins more hearts on Wall Street as 'top 4' Morgan Stanley pick

    http://www.fiercepharma.com/story/actavis-wins-more-hearts-wall-street-top-4-morgan-stanley-pick/2015-05-19

     Carly Helfand FIERCE PHARMA
    19 May 2015
    Share Share
    Drug shortages become issue in Teva and Mylan hook-up
    Drug shortages become issue in Teva and Mylan hook-up

    http://www.fiercepharmamanufacturing.com/story/drug-shortages-becomes-issue-teva-and-mylan-hook/2015-04-30

    Eric Palmer FIERCE PHARMA MANUFACTURING
    30 Apr 2015
    Share Share
    EMA Recommends Hundreds of Drugs to be Suspended Over
    EMA Recommends Hundreds of Drugs to be Suspended Over "Flawed Studies"

    http://blogs.wsj.com/pharmalot/2015/01/23/ema-recommends-hundreds-of-drugs-to-be-suspended-over-flawed-studies/

    Ed Silverman PHARMALOT
    24 Jan 2015
    Share Share
    Actavis High Blood Pressure Drug Fails to Win U.S. Approval
    Actavis High Blood Pressure Drug Fails to Win U.S. Approval

    http://www.bloomberg.com/news/2014-12-24/actavis-high-blood-pressure-drug-fails-to-win-u-s-approval.html

    Anna Edney BLOOMBERG
    25 Dec 2014
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search